Compare Abeona Therapeutics Inc (ABEO) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs MasTec Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while MasTec Inc trades at $280.2 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 52× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MTZ | |
|---|---|---|
Market Cap | $421.19M | $21.90B |
Sector | Health | Technology |
52-Week High | $7.45 | $437.51 |
52-Week Low | $4.17 | $172.51 |
Enterprise Value | $276.10M | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
